Literature DB >> 1618952

Optimization of high-performance liquid chromatographic assay for catecholamines. Determination of optimal mobile phase composition and elimination of species-dependent differences in extraction recovery of 3,4-dihydroxybenzylamine.

H B He1, R J Deegan, M Wood, A J Wood.   

Abstract

This paper describes the application of a window diagram technique to optimize the four components of eluent (sodium acetate, sodium heptanesulfonate, acetonitrile and pH adjusted by monochloroacetic acid), for complete separation of five catecholamine compounds and the internal standard (3,4-dihydroxybenzylamine, DHBA). In addition, studies were performed to address the problem of the variable recovery of DHBA from dog plasma due to a time-dependent loss of DHBA. We found that this phenomenon can be prevented by pH adjustment prior to addition of DHBA, allowing development of an accurate high-performance liquid chromatographic assay for plasma catecholamines in dogs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618952

Source DB:  PubMed          Journal:  J Chromatogr


  13 in total

1.  Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.

Authors:  Utkarsh Kohli; André Diedrich; Prince J Kannankeril; Mordechai Muszkat; Gbenga G Sofowora; Maureen K Hahn; Brett A English; Randy D Blakely; C Michael Stein; Daniel Kurnik
Journal:  Physiol Genomics       Date:  2015-06-09       Impact factor: 3.107

2.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Authors:  C M Stein; R Nelson; R Deegan; H He; M Wood; A J Wood
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans.

Authors:  Utkarsh Kohli; Maureen K Hahn; Brett A English; Gbenga G Sofowora; Mordechai Muszkat; Chun Li; Randy D Blakely; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

4.  Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.

Authors:  Daniel Kurnik; Mordechai Muszkat; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mika Scheinin; Alastair J J Wood; C Michael Stein
Journal:  Circ Cardiovasc Genet       Date:  2011-02-15

5.  Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women.

Authors:  Gbemiga G Sofowora; Iqbal Singh; Huai B He; Alastair J J Wood; C Michael Stein
Journal:  Clin Auton Res       Date:  2005-06       Impact factor: 4.435

6.  Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.

Authors:  Laxmi V Ghimire; Utkarsh Kohli; Chun Li; Gbenga G Sofowora; Mordechai Muszkat; Eitan A Friedman; Joseph F Solus; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

7.  Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.

Authors:  Daniel Kurnik; Eitan A Friedman; Mordechai Muszkat; Gbenga G Sofowora; Hong-Guang Xie; William D Dupont; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

8.  Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.

Authors:  Laxmi V Ghimire; Mordechai Muszkat; Gbenga G Sofowora; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

9.  Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites.

Authors:  Abiodun Adefurin; Laxmi V Ghimire; Utkarsh Kohli; Mordechai Muszkat; Gbenga G Sofowora; Sachin Y Paranjape; C Michael Stein; Daniel Kurnik
Journal:  Hypertension       Date:  2013-02-11       Impact factor: 10.190

10.  Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.

Authors:  Mayur B Patel; John W McKenna; JoAnn M Alvarez; Ayaka Sugiura; Judith M Jenkins; Oscar D Guillamondegui; Pratik P Pandharipande
Journal:  Trials       Date:  2012-09-26       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.